Zdrowie i gospodarka · 07/03/2003

FDA Announces Submission of Information Collection for New Drug Review Process

The Food and Drug Administration (FDA) is seeking public comment on a proposed collection of information related to the review of new drugs, which has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.